Neurologic event-free survival demonstrates a benefit for SCID patients diagnosed by newborn screening
Blood Adv
.
2017 Sep 5;1(20):1694-1698.
doi: 10.1182/bloodadvances.2017010835.
eCollection 2017 Sep 12.
Authors
Christopher C Dvorak
1
,
Jennifer M Puck
1
,
Justin T Wahlstrom
1
,
Morna Dorsey
1
,
Alexis Melton
1
,
Morton J Cowan
1
Affiliation
1
Division of Pediatric Allergy, Immunology and Bone Marrow Transplantation, Benioff Children's Hospital, University of California San Francisco, San Francisco, CA.
PMID:
29296816
PMCID:
PMC5728344
DOI:
10.1182/bloodadvances.2017010835
No abstract available
Grants and funding
R01 AI105776/AI/NIAID NIH HHS/United States
T32 CA128583/CA/NCI NIH HHS/United States
U54 AI082973/AI/NIAID NIH HHS/United States